豫園股份(600655.SH):擬向復星消費與科技基金一期繼續增資3億元
格隆匯6月3日丨豫園股份(600655.SH)公佈,經豫園股份第十屆董事會第七次會議審議,豫園股份擬向復星消費與科技基金一期繼續增資3億元。同時,普通合夥人與復星高科擬簽署《財產份額轉讓協議書》,根據轉讓協議,復星高科將其在本基金中持有的尚未實繳的人民幣300萬元的認繳出資額以及該等認繳出資額對應的權利和義務轉讓給普通合夥人。此次新增認繳出資及轉讓後,普通合夥人認繳出資額780萬元(基金出資佔比1%),豫園有限合夥人認繳出資額6億元(基金出資佔比76.92%),復星高科認繳出資額1.722億元(基金出資佔比22.08%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.